Nothing Special   »   [go: up one dir, main page]

ATE439859T1 - Transferrin bindende proteine aus neisseria- gonorrhoeae und neisseria-meningitidis. ihre verwendung in einem impfstoff - Google Patents

Transferrin bindende proteine aus neisseria- gonorrhoeae und neisseria-meningitidis. ihre verwendung in einem impfstoff

Info

Publication number
ATE439859T1
ATE439859T1 AT02028655T AT02028655T ATE439859T1 AT E439859 T1 ATE439859 T1 AT E439859T1 AT 02028655 T AT02028655 T AT 02028655T AT 02028655 T AT02028655 T AT 02028655T AT E439859 T1 ATE439859 T1 AT E439859T1
Authority
AT
Austria
Prior art keywords
neisseria
neisseria gonorrhoeae
iron
regulated
vaccine
Prior art date
Application number
AT02028655T
Other languages
English (en)
Inventor
P Frederick Sparling
Cynthia Nau Cornelissen
Original Assignee
Univ North Carolina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ North Carolina filed Critical Univ North Carolina
Application granted granted Critical
Publication of ATE439859T1 publication Critical patent/ATE439859T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1217Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Neisseriaceae (F)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT02028655T 1990-08-23 1991-08-23 Transferrin bindende proteine aus neisseria- gonorrhoeae und neisseria-meningitidis. ihre verwendung in einem impfstoff ATE439859T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57218790A 1990-08-23 1990-08-23

Publications (1)

Publication Number Publication Date
ATE439859T1 true ATE439859T1 (de) 2009-09-15

Family

ID=24286735

Family Applications (2)

Application Number Title Priority Date Filing Date
AT02028655T ATE439859T1 (de) 1990-08-23 1991-08-23 Transferrin bindende proteine aus neisseria- gonorrhoeae und neisseria-meningitidis. ihre verwendung in einem impfstoff
AT91918802T ATE253114T1 (de) 1990-08-23 1991-08-23 Transferrin bindende proteine aus neisseria- gonorrhoeae und neisseria-meningitidis

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT91918802T ATE253114T1 (de) 1990-08-23 1991-08-23 Transferrin bindende proteine aus neisseria- gonorrhoeae und neisseria-meningitidis

Country Status (10)

Country Link
US (1) US7582730B2 (de)
EP (2) EP0546118B1 (de)
JP (3) JP3532563B2 (de)
AT (2) ATE439859T1 (de)
AU (1) AU8747791A (de)
CA (1) CA2087958C (de)
DE (2) DE69133622D1 (de)
DK (2) DK1378245T3 (de)
ES (2) ES2329979T3 (de)
WO (1) WO1992003467A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6086896A (en) * 1990-07-16 2000-07-11 Imclone Systems Incorporated Antigenic iron repressible protein from N. meningitidis related to the hemolysin family of toxins
US6887482B2 (en) 1990-07-16 2005-05-03 The University Of North Carolina At Chapel Hill Antigenic iron repressible proteins from N. meningitidis related to the hemolysin family of toxins
FR2682114B1 (fr) * 1991-10-03 1996-02-23 Pasteur Merieux Serums Vacc Vaccin de sous-unite contre les infections a neisseria meningitidis et sous-unites correspondantes a l'etat purifie.
FR2692592B1 (fr) 1992-06-19 1995-03-31 Pasteur Merieux Serums Vacc Fragments d'ADN codant pour les sous-unités du récepteur de la transferrine de Neisseria meningitidis et procédés les exprimant.
US5439808A (en) * 1993-07-23 1995-08-08 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
FR2724936A1 (fr) * 1994-09-22 1996-03-29 Pasteur Merieux Serums Vacc Recepteur lactoferrine d'helicobacter
US5747287A (en) * 1995-04-28 1998-05-05 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
JPH11502418A (ja) * 1995-10-09 1999-03-02 パストゥール メリユ セリュム エ ヴァサン ヘリコバクターのラクトフェリン受容体
US6610506B1 (en) 1995-12-01 2003-08-26 University Technologies International, Inc. Transferrin binding proteins of Pasteurella haemolytica and vaccines containing same
GB9726398D0 (en) 1997-12-12 1998-02-11 Isis Innovation Polypeptide and coding sequences
PT1944371E (pt) * 1998-05-01 2015-07-13 Novartis Ag Antigénios e composições da neisseria meningitidis
US6692752B1 (en) 1999-09-08 2004-02-17 Smithkline Beecham Biologicals S.A. Methods of treating human females susceptible to HSV infection
CA2347849C (en) * 1998-10-22 2013-06-25 The University Of Montana Omp85 proteins of neisseria gonorrhoeae and neisseria meningitidis, compositions containing same and methods of use thereof
EP1535928B1 (de) * 1998-10-22 2008-07-16 The University of Montana Vakzine enthaltend Omp85 Proteine von Neisseria gonorrhoeae und Neisseria meningitidis
US6610306B2 (en) 1998-10-22 2003-08-26 The University Of Montana OMP85 protein of neisseria meningitidis, compositions containing the same and methods of use thereof
DE69839740D1 (de) 1998-10-22 2008-08-28 Univ Montana Vakzine enthaltend Omp85 Proteine von Neisseria gonorrhoeae und Neisseria meningitidis
EP1069133A1 (de) * 1999-07-13 2001-01-17 Institut National De La Sante Et De La Recherche Medicale (Inserm) Neisseria meningitidis Zusammensetzungen und ihre Verwendungen als anti-infektionsmitteln
MXPA02004283A (es) * 1999-10-29 2002-10-17 Chiron Spa Peptidos antigenicos neisseriales.
NZ587398A (en) 2002-08-02 2012-03-30 Glaxosmithkline Biolog Sa Neisserial bleb preparations and vaccines comprising them
DK1556477T3 (en) 2002-11-01 2017-10-23 Glaxosmithkline Biologicals Sa Process for drying
DK1670506T3 (da) 2003-10-02 2013-02-25 Novartis Ag Flydende vacciner mod multiple meningococserogrupper
AU2004277342B2 (en) 2003-10-02 2010-12-16 Glaxosmithkline Biologicals S.A. Pertussis antigens and use thereof in vaccination
GB0505996D0 (en) 2005-03-23 2005-04-27 Glaxosmithkline Biolog Sa Fermentation process
US20090123499A1 (en) 2006-06-12 2009-05-14 Nathalie Devos Vaccine
GB0700562D0 (en) 2007-01-11 2007-02-21 Novartis Vaccines & Diagnostic Modified Saccharides
CA2792689A1 (en) 2010-03-10 2011-09-15 Glaxosmithkline Biologicals S.A. Immunogenic composition
PT2646470T (pt) 2010-11-30 2017-05-03 Hoffmann La Roche Anticorpos anti-recetor da transferrina de baixa afinidade e a sua utilização na transferência de scfv terapêuticos através da barreira hematoencefálica
CA3031442A1 (en) * 2016-07-18 2018-01-25 Cell Idx, Inc. Antigen-coupled hybridization reagents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4681761A (en) * 1985-10-24 1987-07-21 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Major iron-regulated protein of Neisseria gonorrhoeae and its use as vaccine
US5141743A (en) * 1989-04-27 1992-08-25 University Technologies International, Inc. Method for isolating and purifying transferrin and lactoferrin receptor proteins and vaccines containing the same
US5292869A (en) * 1989-04-27 1994-03-08 The Board Of Governors Of The University Method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same
US5912336A (en) * 1990-08-23 1999-06-15 University Of North Carolina At Chapel Hill Isolated nucleic acid molecules encoding transferrin binding proteins from Neisseria gonorrhoeae and Neisseria meningitidis
FR2692592B1 (fr) 1992-06-19 1995-03-31 Pasteur Merieux Serums Vacc Fragments d'ADN codant pour les sous-unités du récepteur de la transferrine de Neisseria meningitidis et procédés les exprimant.

Also Published As

Publication number Publication date
DE69133622D1 (de) 2009-10-01
ES2329979T3 (es) 2009-12-03
DE69133334T2 (de) 2004-05-13
US20070065453A1 (en) 2007-03-22
JP2005239548A (ja) 2005-09-08
CA2087958A1 (en) 1992-02-24
ATE253114T1 (de) 2003-11-15
WO1992003467A1 (en) 1992-03-05
ES2210228T3 (es) 2004-07-01
EP1378245B1 (de) 2009-08-19
JPH06500562A (ja) 1994-01-20
EP1378245A2 (de) 2004-01-07
EP0546118A1 (de) 1993-06-16
JP3532563B2 (ja) 2004-05-31
JP2002186489A (ja) 2002-07-02
EP0546118A4 (en) 1993-07-14
EP1378245A3 (de) 2004-01-14
US7582730B2 (en) 2009-09-01
DK0546118T3 (da) 2004-02-16
CA2087958C (en) 2007-05-15
AU8747791A (en) 1992-03-17
EP0546118B1 (de) 2003-10-29
DK1378245T3 (da) 2009-10-26
DE69133334D1 (de) 2003-12-04

Similar Documents

Publication Publication Date Title
ATE439859T1 (de) Transferrin bindende proteine aus neisseria- gonorrhoeae und neisseria-meningitidis. ihre verwendung in einem impfstoff
DK0503648T3 (da) CD2-bindingsdomæne af lymfocytfunktion-associeret antigen 3
ATE162723T1 (de) Die induktion der antikörperantwort gegen eigene proteine mit hilfe fremder t-zellepitope
ATE142230T1 (de) Bispezifische und oligospezifische, mono- und oligovalente rezeptoren, ihre herstellung und verwendung
FI981807A (fi) Menetelmä terapeuttisesti käyttökelpoisten starburst-konjugaattien valmistamiseksi
DE69632625D1 (de) Mykrobakterielle proteine, mikroorganismen welche diese produzieren und ihre verwendung als impfstoff und zum nachweis von zuberkulose
ATE167516T1 (de) Colostrum fraktion und ihre verwendung als additiv beim zellkulturmedium
CA2056279A1 (en) Cell-free receptor binding assays, the production and use thereof
CY1109202T1 (el) Συνθεσεις που περιεχουν αντιγονα απο τους οροτυπους b και c της neisseria meningitidis οπως και επιπλεον αντιγονα απο τον οροτυπο α
DE68916537D1 (de) Herstellung eines insulinähnlichen, wachstümsfaktor bindenden proteins.
ATE403680T1 (de) Herstellung tetravalenter antikörper
DK0754229T3 (da) Afamin: et humant serum albumin-lignende protein
DK1129186T3 (da) Et faktor VIII-polypeptid med faktor VIII:C-aktivitet
DE59101580D1 (de) Trägergebundene rekombinante proteine, verfahren zur herstellung und verwendung als immunogene und vakzine.
DE69123121D1 (de) Synthetischer poly-ig-rezeptor, rezeptor-antikörper-komplexe, herstellung und anwendung
ATE125270T1 (de) Tert-butyloxycarbonyl-l-tyrosyl- peptidoglycanmonomer und deren 125 i-markiertes derivat, deren herstellung und verwendung.
DE59106997D1 (de) Ancrod ähnliche proteine, ihre herstellung und verwendung.
ES274547U (es) Almohadilla plegable
ES1033817U (es) Soporte armable para bolsas.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1378245

Country of ref document: EP

EELA Cancelled due to lapse of time